The overall result, an 8% increase in infant mortality, was almost exactly the same as that in our previous trial of normal birthweight infants.
Dr Venn discusses a paper by Waters et al. [ 5], who conducted a randomized trial of normal saline versus Ringer's lactate and found no difference in outcomes despite the propensity of normal saline to provoke an iatrogenic hyperchloraemic acidosis.
Private obstetricians said that they usually avoid a trial of normal labour and delivery as it increases the chance of emergency Caesarean delivery, which is always challenging in single doctor practices without ready availability of blood and an anaesthetist: "Now here we are, single handed practitioner, and without teamwork; to tackle such emergency is difficult".
The task was designed such that the optimal target switch time was dependent on the proportion of probe trials to normal trials: when the proportion was high, the danger of switching too late was larger than the danger of switching too early (and vice-versa).
Hence, neo-natal deaths are occurring more because of the long trial for normal delivery resulting in delay and foetal distress.
Because of a disproportionately large number of "response" trials in normal control group (i.e. participants with aMCI were much more likely to provide no response), control participant RM scores may have disproportionately benefited from "automatic" 1 RM score awarding on "response" trials and generated an apparent group RM component difference.
The exclusion criteria ranged from a baseline serum creatinine concentration below 1.27 mg·dL−1 for the alendronate trials; 1.1× the upper limit of normal for the risedronate registration trials; <2.4 mg·dL−1 for the ibandronate trials; or eGFR >30 mL·min−1 (zoledronic acid and denosumab trials)).
Eight articles were subsequently excluded in which 4 trials had their control groups engaged in some forms of exercise [ 31– 34], 2 trials had no control group [ 35, 36], and 2 trials had control groups of normal healthy participants that did not meet the inclusion criteria [ 37, 38].
For example, pragmatic trials enroll patients typical of normal caseload in typical settings with average physicians following them under routine conditions [ 10].
For example, ideally, pragmatic trials enrol patients typical of normal caseload in typical settings with typically trained and experienced practitioners following them under routine conditions (ref. 37, p. 251).
Three (5.3%) of 56 patients were excluded from this trial because of intolerability of normal tissue (tumor located at basal ganglia or gliomatosis cerebri).
